Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$209.01 - $232.56 $31,351 - $34,884
150 Added 1.39%
10,927 $2.39 Million
Q4 2023

Jan 19, 2024

SELL
$197.69 - $227.29 $1,186 - $1,363
-6 Reduced 0.06%
10,777 $2.45 Million
Q3 2023

Oct 17, 2023

BUY
$201.05 - $221.7 $8,042 - $8,868
40 Added 0.37%
10,783 $2.17 Million
Q2 2023

Jul 21, 2023

BUY
$211.93 - $241.33 $8,265 - $9,411
39 Added 0.36%
10,743 $2.59 Million
Q1 2023

Apr 26, 2023

BUY
$213.32 - $257.83 $14,719 - $17,790
69 Added 0.65%
10,704 $2.46 Million
Q4 2022

Jan 18, 2023

BUY
$203.72 - $248.97 $29,743 - $36,349
146 Added 1.39%
10,635 $0
Q3 2022

Oct 17, 2022

SELL
$204.81 - $262.19 $18,432 - $23,597
-90 Reduced 0.85%
10,489 $2.15 Million
Q2 2022

Jul 11, 2022

BUY
$213.86 - $277.87 $8,982 - $11,670
42 Added 0.4%
10,579 $2.48 Million
Q1 2022

Apr 25, 2022

SELL
$259.82 - $298.18 $23,123 - $26,538
-89 Reduced 0.84%
10,537 $2.78 Million
Q4 2021

Jan 21, 2022

SELL
$271.6 - $314.21 $38,024 - $43,989
-140 Reduced 1.3%
10,626 $3.34 Million
Q3 2021

Oct 26, 2021

SELL
$274.82 - $308.34 $50,841 - $57,042
-185 Reduced 1.69%
10,766 $3.03 Million
Q2 2021

Aug 02, 2021

SELL
$251.87 - $278.14 $40,299 - $44,502
-160 Reduced 1.44%
10,951 $3.02 Million
Q1 2021

Apr 29, 2021

SELL
$204.88 - $255.03 $51,220 - $63,757
-250 Reduced 2.2%
11,111 $2.83 Million
Q4 2020

Jan 28, 2021

SELL
$186.91 - $214.42 $53,269 - $61,109
-285 Reduced 2.45%
11,361 $2.31 Million
Q3 2020

Oct 23, 2020

BUY
$167.03 - $201.3 $2,171 - $2,616
13 Added 0.11%
11,646 $2.19 Million
Q2 2020

Aug 04, 2020

SELL
$113.31 - $182.44 $6,118 - $9,851
-54 Reduced 0.46%
11,633 $1.93 Million
Q1 2020

Apr 24, 2020

SELL
$104.32 - $195.28 $11,266 - $21,090
-108 Reduced 0.92%
11,687 $1.48 Million
Q4 2019

Jan 23, 2020

BUY
$163.48 - $173.61 $18,800 - $19,965
115 Added 0.98%
11,795 $2 Million
Q3 2019

Oct 21, 2019

SELL
$159.77 - $178.1 $51,126 - $56,992
-320 Reduced 2.67%
11,680 $1.96 Million
Q2 2019

Jul 26, 2019

SELL
$144.16 - $172.9 $46,852 - $56,192
-325 Reduced 2.64%
12,000 $2.08 Million
Q1 2019

Apr 23, 2019

SELL
$123.7 - $156.3 $3,092 - $3,907
-25 Reduced 0.2%
12,325 $1.89 Million
Q4 2018

Jan 23, 2019

SELL
$120.82 - $174.09 $12,082 - $17,409
-100 Reduced 0.8%
12,350 $1.56 Million
Q3 2018

Oct 23, 2018

SELL
$167.67 - $188.27 $6,706 - $7,530
-40 Reduced 0.32%
12,450 $2.16 Million
Q2 2018

Aug 03, 2018

BUY
$160.33 - $189.41 $22,446 - $26,517
140 Added 1.13%
12,490 $2.24 Million
Q1 2018

Apr 18, 2018

BUY
$161.53 - $178.11 $273,793 - $301,896
1,695 Added 15.91%
12,350 $2 Million
Q4 2017

Feb 14, 2018

BUY
$147.99 - $163.95 $1.58 Million - $1.75 Million
10,655
10,655 $1.7 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track New Potomac Partners, LLC Portfolio

Follow New Potomac Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Potomac Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Potomac Partners, LLC with notifications on news.